Ann: Pfizer raises scheme consideration to A$0.208 per share, page-22

I wonr be selling - I want to look back in 10 years when this tech is part of mainstream health provision and giving healthy dividends. I don’t want to be kicking myself for selling out - I invested for the long-term - I believe in the technology. I’m here for the ride - the ups and the downs and also what I believe to be the rewards- which will be great. REsApl will be up their with cochlear when we think of medical stocks.

dyor - all my own enlightened belief .